XML 31 R13.htm IDEA: XBRL DOCUMENT
v3.25.2

Accrued Litigation Settlement Expenses | 6 Months Ended
--- | ---
Jun. 30, 2025
Commitments and Contingencies Disclosure [Abstract] |
Accrued Litigation Settlement Expenses | 7. Accrued Litigation Settlement Expenses
| June 30, 2025 |  | December 31, 2024
| Current |  | Non current |  | Total |  | Current |  | Non current |  | Total
Accrued litigation settlement expenses |  |  |  |  |  |  |  |  |  |  |
DOJ-related | $ | 51 |  |  | $ | 247 |  |  | $ | 298 |  |  | $ | 52 |  |  | $ | 296 |  |  | $ | 348 |
Antitrust claims | 20 |  |  | — |  |  | 20 |  |  | 24 |  |  | — |  |  | 24 |
Opioid litigation | 27 |  |  | 52 |  |  | 79 |  |  | 15 |  |  | 61 |  |  | 76 |
Other | 8 |  |  | — |  |  | 8 |  |  | 8 |  |  | 8 |  |  | 16 |
Total accrued litigation settlement expenses | $ | 105 |  |  | $ | 299 |  |  | $ | 404 |  |  | $ | 99 |  |  | $ | 365 |  |  | $ | 464 |
DOJ-related In July 2020, the Company settled criminal and civil liability with the U.S. Department of Justice (DOJ), the U.S. Federal Trade Commission (FTC), and U.S. state attorneys general. A scheduled payment of $52 million was made during the six months ended June 30, 2025 with respect to this matter. Opioid litigation The accrual of $79 million at June 30, 2025 reflects the present value of the agreed amount in a settlement covering certain opioid litigation (including cases in the Opioid MDL). The provision is measured using a risk-free rate. Antitrust claims An installment of $5 million was paid in the six months ended June 30, 2025 in relation to the last remaining antitrust litigation. The remaining accrual of $20 million at June 30, 2025 reflects the NPV at the risk-free rate of the amounts to be paid in 2025. This final settlement resolves all of the Company’s remaining legacy antitrust litigation. See Note 12. Commitments and Contingencies for additional information on legal matters.

X
- References No definition available. + Details
Name: | us-gaap_CommitmentsAndContingenciesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 450 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/450/tableOfContent + Details
Name: | us-gaap_LegalMattersAndContingenciesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration